• Corticotropin Releasing Hormone (CRH)
  • Cytomegalovirus (CMV) Genotyping and Drug Resistance
  • Extended Thyroid Panel
  • HLA-B*57:01 Genotype, Abacavir Sensitivity
  • Spinocerebellar Ataxia Type 2 (ATXN2) Gene Mutation Analysis
  • Cannabinoid, Urine
  • Ethotoin, Serum or Plasma
  • FLG (filaggrin) Gene Mutation Analysis
  • Prostaglandin D2 (PGD2), Serum
  • Acid Phosphatase, Total, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Solute carrier family 6 member 2 (SLC6A2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Solute carrier family 6 member 2 (SLC6A2)
Medical Test

Clinical Utility
Access to Solute carrier family 6 member 2 (SLC6A2) is restricted.
Loading...